NO20034159D0 - Östrogen-gestagen-kombinasjonspreparat og anvendelse derav - Google Patents

Östrogen-gestagen-kombinasjonspreparat og anvendelse derav

Info

Publication number
NO20034159D0
NO20034159D0 NO20034159A NO20034159A NO20034159D0 NO 20034159 D0 NO20034159 D0 NO 20034159D0 NO 20034159 A NO20034159 A NO 20034159A NO 20034159 A NO20034159 A NO 20034159A NO 20034159 D0 NO20034159 D0 NO 20034159D0
Authority
NO
Norway
Prior art keywords
estrogen
combination preparation
gestagen combination
gestagen
preparation
Prior art date
Application number
NO20034159A
Other languages
English (en)
Other versions
NO20034159L (no
Inventor
Diethard Schwanitz
Jutta Rogoll
Bernd Hachmeister
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO20034159L publication Critical patent/NO20034159L/no
Publication of NO20034159D0 publication Critical patent/NO20034159D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20034159A 2001-09-29 2003-09-18 Östrogen-gestagen-kombinasjonspreparat og anvendelse derav NO20034159D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01123511 2001-09-29
PCT/EP2002/010728 WO2003028735A1 (de) 2001-09-29 2002-09-25 Estrogen-gestagen kombinationspräparat und anwendung

Publications (2)

Publication Number Publication Date
NO20034159L NO20034159L (no) 2003-09-18
NO20034159D0 true NO20034159D0 (no) 2003-09-18

Family

ID=8178810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034159A NO20034159D0 (no) 2001-09-29 2003-09-18 Östrogen-gestagen-kombinasjonspreparat og anvendelse derav

Country Status (16)

Country Link
US (1) US20040266745A1 (no)
EP (1) EP1434586A1 (no)
JP (1) JP2005507394A (no)
KR (1) KR20040037097A (no)
CN (1) CN1561217A (no)
BR (1) BRPI0208558A2 (no)
CA (1) CA2462075A1 (no)
DE (1) DE10294402D2 (no)
HU (1) HUP0402142A2 (no)
IL (1) IL161105A0 (no)
MX (1) MXPA04002771A (no)
NO (1) NO20034159D0 (no)
PL (1) PL373494A1 (no)
RU (1) RU2004113305A (no)
WO (1) WO2003028735A1 (no)
ZA (1) ZA200402458B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
TW200404551A (en) * 2002-05-17 2004-04-01 Wyeth Corp Hormone replacement therapy
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
WO2005120432A1 (en) * 2004-06-07 2005-12-22 Duramed Pharmaceuticals, Inc. Dispenser for progestin used for acute and maintenance treatment of dub
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
JP5675068B2 (ja) * 2009-07-13 2015-02-25 株式会社ミューチュアル 充填装置
US8991607B2 (en) 2010-03-18 2015-03-31 Medcomb Holding Aps System for opening a medical blister package
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method

Also Published As

Publication number Publication date
CA2462075A1 (en) 2003-04-10
CN1561217A (zh) 2005-01-05
RU2004113305A (ru) 2005-07-10
MXPA04002771A (es) 2004-06-29
US20040266745A1 (en) 2004-12-30
EP1434586A1 (de) 2004-07-07
BRPI0208558A2 (pt) 2017-05-23
DE10294402D2 (de) 2004-11-11
KR20040037097A (ko) 2004-05-04
PL373494A1 (en) 2005-09-05
HUP0402142A2 (hu) 2005-02-28
JP2005507394A (ja) 2005-03-17
WO2003028735A1 (de) 2003-04-10
ZA200402458B (en) 2006-07-26
NO20034159L (no) 2003-09-18
IL161105A0 (en) 2004-08-31

Similar Documents

Publication Publication Date Title
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20034159L (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
DK1423376T3 (da) Bicyklisk forbindelse, fremstilling og anvendelse deraf
EE200300544A (et) 4-anilinokinoliin-3-karboksamiidid, nende kasutamine ning valmistamine
DE50203203D1 (de) Sende- und empfangseinheit
DK1455785T3 (da) Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse
DE60212600D1 (de) Audiocodierung und decodierung
DE50112013D1 (de) Deodorantien und antiperspirantien
IS7275A (is) Samsetning fyrir hollegg og notkun á henni
ATE299873T1 (de) Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate
DE60205008D1 (de) Kettelverfahren und -vorrichtung
DK1317478T3 (da) Skelnen mellem GnRH-I og GnRH-II
EP1367123A4 (en) NEUROTONIN AND ITS USE
DE60219418T8 (de) Silanylphenole und -naphthole
DE50207062D1 (de) Aufnahmeelement und Gegenstand mit Aufnahmeelement
GB0200843D0 (en) Benzodioxinopyrroles their preparation and use
ITMI20011210A0 (it) Corticosteroidi-21-glicolati e 21-acilglicolati
NO20042856L (no) Substituerte 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner og anvendelse av samme
SE0104404D0 (sv) New methods and use
UY3298Q (es) Configuración aplicada en la licuadora
SE0100590D0 (sv) New composition and use
FI20010586A0 (fi) Painikejärjestely ja painike-lukko-yhdistelmä
FI20010218A0 (fi) Andewin alennus- ja vaihde-laatikko
NO20015559D0 (no) Kreklinggel±
BRMU8103332U2 (pt) terço fácil

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
FC2A Withdrawal, rejection or dismissal of laid open patent application